

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | gonadal mesoderm development (GO:0007506) | 7.62245259 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.49018403 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.49018403 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.08429679 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 6.08429679 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.97759619 |
| 7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.92138475 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.83727312 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 5.29069870 |
| 10 | kynurenine metabolic process (GO:0070189) | 5.27252303 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 5.22347887 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 5.22347887 |
| 13 | tryptophan catabolic process (GO:0006569) | 5.22347887 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.14190265 |
| 15 | complement activation, alternative pathway (GO:0006957) | 4.94069152 |
| 16 | tryptophan metabolic process (GO:0006568) | 4.92675427 |
| 17 | regulation of fibrinolysis (GO:0051917) | 4.90740329 |
| 18 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88178952 |
| 19 | protein carboxylation (GO:0018214) | 4.88178952 |
| 20 | urea metabolic process (GO:0019627) | 4.87944032 |
| 21 | urea cycle (GO:0000050) | 4.87944032 |
| 22 | bile acid biosynthetic process (GO:0006699) | 4.87641042 |
| 23 | regulation of protein activation cascade (GO:2000257) | 4.86322593 |
| 24 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85467209 |
| 25 | reverse cholesterol transport (GO:0043691) | 4.76256357 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.74591872 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 4.67254303 |
| 28 | sulfur amino acid catabolic process (GO:0000098) | 4.55727458 |
| 29 | phospholipid efflux (GO:0033700) | 4.52327620 |
| 30 | regulation of complement activation (GO:0030449) | 4.52056871 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51578078 |
| 32 | complement activation, classical pathway (GO:0006958) | 4.48732526 |
| 33 | cysteine metabolic process (GO:0006534) | 4.43823851 |
| 34 | regulation of cholesterol esterification (GO:0010872) | 4.42754788 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.41822046 |
| 36 | negative regulation of cholesterol transport (GO:0032375) | 4.37210994 |
| 37 | negative regulation of sterol transport (GO:0032372) | 4.37210994 |
| 38 | regulation of triglyceride catabolic process (GO:0010896) | 4.34170801 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.33983064 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.31851865 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.31851865 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.31851865 |
| 43 | bile acid metabolic process (GO:0008206) | 4.29107757 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.26632091 |
| 45 | complement activation (GO:0006956) | 4.24189837 |
| 46 | plasma lipoprotein particle clearance (GO:0034381) | 4.22454080 |
| 47 | aromatic amino acid family metabolic process (GO:0009072) | 4.15635499 |
| 48 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.14146559 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.06143522 |
| 50 | blood coagulation, intrinsic pathway (GO:0007597) | 4.04321947 |
| 51 | cholesterol efflux (GO:0033344) | 4.01319898 |
| 52 | triglyceride homeostasis (GO:0070328) | 3.98204906 |
| 53 | acylglycerol homeostasis (GO:0055090) | 3.98204906 |
| 54 | phospholipid homeostasis (GO:0055091) | 3.97621522 |
| 55 | regulation of apoptotic cell clearance (GO:2000425) | 3.89468382 |
| 56 | ethanol oxidation (GO:0006069) | 3.84727230 |
| 57 | plasma lipoprotein particle assembly (GO:0034377) | 3.84495092 |
| 58 | protein activation cascade (GO:0072376) | 3.84189569 |
| 59 | regulation of cholesterol homeostasis (GO:2000188) | 3.75204873 |
| 60 | homocysteine metabolic process (GO:0050667) | 3.73980368 |
| 61 | negative thymic T cell selection (GO:0045060) | 3.73824973 |
| 62 | regulation of gamma-delta T cell activation (GO:0046643) | 3.72310604 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 3.72310538 |
| 64 | lysine metabolic process (GO:0006553) | 3.70137540 |
| 65 | lysine catabolic process (GO:0006554) | 3.70137540 |
| 66 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.69699952 |
| 67 | protein-lipid complex assembly (GO:0065005) | 3.67558583 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.67433537 |
| 69 | alpha-amino acid catabolic process (GO:1901606) | 3.67088722 |
| 70 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.64699111 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.63511080 |
| 72 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.63181732 |
| 73 | negative regulation of cell killing (GO:0031342) | 3.62360036 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.62360036 |
| 75 | low-density lipoprotein particle remodeling (GO:0034374) | 3.61437134 |
| 76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61032828 |
| 77 | positive regulation of B cell differentiation (GO:0045579) | 3.60343907 |
| 78 | negative T cell selection (GO:0043383) | 3.59646159 |
| 79 | fibrinolysis (GO:0042730) | 3.58111769 |
| 80 | indolalkylamine metabolic process (GO:0006586) | 3.57592226 |
| 81 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.56701941 |
| 82 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.56701941 |
| 83 | positive regulation of lipid catabolic process (GO:0050996) | 3.55956402 |
| 84 | exogenous drug catabolic process (GO:0042738) | 3.54197323 |
| 85 | positive regulation of humoral immune response (GO:0002922) | 3.52146047 |
| 86 | amino-acid betaine metabolic process (GO:0006577) | 3.47744845 |
| 87 | cellular glucuronidation (GO:0052695) | 3.47156775 |
| 88 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.47129337 |
| 89 | glycine metabolic process (GO:0006544) | 3.46850389 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.45198099 |
| 91 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.42661557 |
| 92 | epoxygenase P450 pathway (GO:0019373) | 3.41031231 |
| 93 | plasma lipoprotein particle organization (GO:0071827) | 3.40734494 |
| 94 | glutamate metabolic process (GO:0006536) | 3.40132840 |
| 95 | acute-phase response (GO:0006953) | 3.39888945 |
| 96 | negative regulation of protein activation cascade (GO:2000258) | 3.39706538 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 3.38377343 |
| 98 | amine catabolic process (GO:0009310) | 3.38377343 |
| 99 | positive thymic T cell selection (GO:0045059) | 3.38120661 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.37310274 |
| 101 | cellular modified amino acid catabolic process (GO:0042219) | 3.37212089 |
| 102 | ketone body metabolic process (GO:1902224) | 3.36535361 |
| 103 | drug catabolic process (GO:0042737) | 3.36263408 |
| 104 | acetyl-CoA metabolic process (GO:0006084) | 3.36090516 |
| 105 | linoleic acid metabolic process (GO:0043651) | 3.35887432 |
| 106 | cellular amino acid catabolic process (GO:0009063) | 3.35553481 |
| 107 | protein-lipid complex subunit organization (GO:0071825) | 3.33723657 |
| 108 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.33299122 |
| 109 | sterol homeostasis (GO:0055092) | 3.33021199 |
| 110 | imidazole-containing compound metabolic process (GO:0052803) | 3.31624763 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.30585023 |
| 112 | lipoprotein metabolic process (GO:0042157) | 3.29790379 |
| 113 | thymic T cell selection (GO:0045061) | 3.25261198 |
| 114 | regulation of cholesterol metabolic process (GO:0090181) | 3.25209790 |
| 115 | response to interleukin-15 (GO:0070672) | 3.21702660 |
| 116 | detection of bacterium (GO:0016045) | 3.21508022 |
| 117 | serine family amino acid metabolic process (GO:0009069) | 3.21449931 |
| 118 | regulation of humoral immune response (GO:0002920) | 3.20114708 |
| 119 | T cell migration (GO:0072678) | 3.19716464 |
| 120 | coenzyme catabolic process (GO:0009109) | 3.17352803 |
| 121 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.16689465 |
| 122 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.16418041 |
| 123 | regulation of B cell differentiation (GO:0045577) | 3.15244372 |
| 124 | short-chain fatty acid metabolic process (GO:0046459) | 3.14576079 |
| 125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.13537484 |
| 126 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.13537484 |
| 127 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.12658640 |
| 128 | arginine metabolic process (GO:0006525) | 3.11228478 |
| 129 | B cell homeostasis (GO:0001782) | 3.08651444 |
| 130 | detection of other organism (GO:0098543) | 3.08235473 |
| 131 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08070031 |
| 132 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08070031 |
| 133 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08070031 |
| 134 | modulation by symbiont of host immune response (GO:0052553) | 3.08070031 |
| 135 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08070031 |
| 136 | modulation by symbiont of host defense response (GO:0052031) | 3.08070031 |
| 137 | negative regulation of humoral immune response (GO:0002921) | 3.04055638 |
| 138 | germinal center formation (GO:0002467) | 3.01274195 |
| 139 | histone H3-K36 demethylation (GO:0070544) | 2.97957523 |
| 140 | omega-hydroxylase P450 pathway (GO:0097267) | 2.96979083 |
| 141 | T cell selection (GO:0045058) | 2.94455693 |
| 142 | ethanol metabolic process (GO:0006067) | 2.88712785 |
| 143 | detection of external biotic stimulus (GO:0098581) | 2.86951461 |
| 144 | positive regulation of blood coagulation (GO:0030194) | 2.86535994 |
| 145 | positive regulation of hemostasis (GO:1900048) | 2.86535994 |
| 146 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.81857198 |
| 147 | positive T cell selection (GO:0043368) | 2.80701532 |
| 148 | immunoglobulin mediated immune response (GO:0016064) | 2.77692662 |
| 149 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.76501258 |
| 150 | cytolysis (GO:0019835) | 2.76419113 |
| 151 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.73391905 |
| 152 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71444865 |
| 153 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71444865 |
| 154 | negative regulation of hemostasis (GO:1900047) | 2.69707471 |
| 155 | negative regulation of blood coagulation (GO:0030195) | 2.69707471 |
| 156 | cellular response to type I interferon (GO:0071357) | 2.69259128 |
| 157 | type I interferon signaling pathway (GO:0060337) | 2.69259128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.38429619 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.76506238 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.99808845 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.45357556 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.15396356 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.09300250 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.83607157 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.72657244 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.46148923 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.00185625 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.95541631 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.54045386 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.23011118 |
| 14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11822529 |
| 15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.11784101 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.07154660 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.89222276 |
| 18 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.89192814 |
| 19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.81921918 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81754313 |
| 21 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.78194002 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.71049974 |
| 23 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.68981201 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64242216 |
| 25 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.63813575 |
| 26 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.63622614 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62687794 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60575828 |
| 29 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.57306978 |
| 30 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57262252 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56578113 |
| 32 | MYC_22102868_ChIP-Seq_BL_Human | 1.53736099 |
| 33 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.52307768 |
| 34 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50541504 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50372229 |
| 36 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.47585830 |
| 37 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.47505058 |
| 38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45077314 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44761702 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44331818 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38924046 |
| 42 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38106429 |
| 43 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33342116 |
| 44 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.30585008 |
| 45 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.27593348 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.24921326 |
| 47 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.24144011 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22222827 |
| 49 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22163074 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.20716265 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19150575 |
| 52 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17318675 |
| 53 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.15575240 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.15044591 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13338990 |
| 56 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.11258722 |
| 57 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09550991 |
| 58 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.07898790 |
| 59 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.07730259 |
| 60 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07720141 |
| 61 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.06263309 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.04237417 |
| 63 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01592553 |
| 64 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00588013 |
| 65 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00359722 |
| 66 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98652784 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.98176204 |
| 68 | UTX_26944678_Chip-Seq_JUKART_Human | 0.97703028 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97536398 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97414430 |
| 71 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.96683676 |
| 72 | MYB_26560356_Chip-Seq_TH2_Human | 0.94958719 |
| 73 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.94054337 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90970804 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90610030 |
| 76 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90442037 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.90375954 |
| 78 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90298158 |
| 79 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88222908 |
| 80 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.87803264 |
| 81 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87357190 |
| 82 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.87339887 |
| 83 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.86902743 |
| 84 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86381794 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85790045 |
| 86 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85559112 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.85461208 |
| 88 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85292239 |
| 89 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84897827 |
| 90 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.84751251 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84462107 |
| 92 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.84015608 |
| 93 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.83838906 |
| 94 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83789409 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.83692533 |
| 96 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83504042 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83470358 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83425525 |
| 99 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83104467 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82437834 |
| 101 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.81896617 |
| 102 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.81447569 |
| 103 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.81129433 |
| 104 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80870352 |
| 105 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78402396 |
| 106 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77708933 |
| 107 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.77160835 |
| 108 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.76241425 |
| 109 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.76192959 |
| 110 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.75390590 |
| 111 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.74837037 |
| 112 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.74692939 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.74134423 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.73717773 |
| 115 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.73441215 |
| 116 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.71488083 |
| 117 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.69319253 |
| 118 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.69164799 |
| 119 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.68890843 |
| 120 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68384782 |
| 121 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.68332232 |
| 122 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.66629502 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.66390631 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66070482 |
| 125 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.65897071 |
| 126 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64803997 |
| 127 | MAF_26560356_Chip-Seq_TH2_Human | 0.64296819 |
| 128 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.63354259 |
| 129 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63323625 |
| 130 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.63015139 |
| 131 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.62776603 |
| 132 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.62295422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.13205661 |
| 2 | MP0005360_urolithiasis | 6.29633379 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.20133796 |
| 4 | MP0005365_abnormal_bile_salt | 5.12940458 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 3.93620480 |
| 6 | MP0009840_abnormal_foam_cell | 3.49052239 |
| 7 | MP0003252_abnormal_bile_duct | 3.47449773 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.14241918 |
| 9 | MP0005083_abnormal_biliary_tract | 3.01407004 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.98930629 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.53573862 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.47360720 |
| 13 | MP0003195_calcinosis | 2.35924988 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.33903815 |
| 15 | MP0000609_abnormal_liver_physiology | 2.23677382 |
| 16 | MP0005332_abnormal_amino_acid | 2.22284711 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.11700155 |
| 18 | MP0003300_gastrointestinal_ulcer | 2.04193880 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.89051639 |
| 20 | MP0002132_abnormal_respiratory_system | 1.68997162 |
| 21 | MP0003868_abnormal_feces_composition | 1.64582470 |
| 22 | MP0004019_abnormal_vitamin_homeostasis | 1.63977116 |
| 23 | MP0002396_abnormal_hematopoietic_system | 1.63114306 |
| 24 | MP0003705_abnormal_hypodermis_morpholog | 1.57638278 |
| 25 | MP0001835_abnormal_antigen_presentation | 1.55243146 |
| 26 | MP0005387_immune_system_phenotype | 1.49129228 |
| 27 | MP0001790_abnormal_immune_system | 1.49129228 |
| 28 | MP0002254_reproductive_system_inflammat | 1.48403796 |
| 29 | MP0000604_amyloidosis | 1.47511195 |
| 30 | MP0001800_abnormal_humoral_immune | 1.47397841 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.45347273 |
| 32 | MP0003172_abnormal_lysosome_physiology | 1.44465336 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42928877 |
| 34 | MP0008057_abnormal_DNA_replication | 1.40666526 |
| 35 | MP0001881_abnormal_mammary_gland | 1.39188907 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.36315110 |
| 37 | MP0000685_abnormal_immune_system | 1.36007003 |
| 38 | MP0000703_abnormal_thymus_morphology | 1.34091424 |
| 39 | MP0005408_hypopigmentation | 1.26032138 |
| 40 | MP0005310_abnormal_salivary_gland | 1.23630490 |
| 41 | MP0003183_abnormal_peptide_metabolism | 1.22787541 |
| 42 | MP0005451_abnormal_body_composition | 1.22450875 |
| 43 | MP0003436_decreased_susceptibility_to | 1.21127774 |
| 44 | MP0000598_abnormal_liver_morphology | 1.20888875 |
| 45 | MP0003866_abnormal_defecation | 1.18750832 |
| 46 | MP0010234_abnormal_vibrissa_follicle | 1.16164618 |
| 47 | MP0002148_abnormal_hypersensitivity_rea | 1.15699516 |
| 48 | MP0001915_intracranial_hemorrhage | 1.12962777 |
| 49 | MP0008260_abnormal_autophagy | 1.12004739 |
| 50 | MP0005058_abnormal_lysosome_morphology | 1.11002844 |
| 51 | MP0008469_abnormal_protein_level | 1.10301356 |
| 52 | MP0010368_abnormal_lymphatic_system | 1.08528614 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.07971499 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.06394819 |
| 55 | * MP0003303_peritoneal_inflammation | 1.05833175 |
| 56 | MP0002006_tumorigenesis | 1.05403945 |
| 57 | MP0000858_altered_metastatic_potential | 1.03498943 |
| 58 | MP0009763_increased_sensitivity_to | 1.02800759 |
| 59 | MP0004947_skin_inflammation | 1.02072931 |
| 60 | * MP0002452_abnormal_antigen_presenting | 1.00121303 |
| 61 | MP0003690_abnormal_glial_cell | 0.99585205 |
| 62 | MP0004264_abnormal_extraembryonic_tissu | 0.99129868 |
| 63 | MP0006082_CNS_inflammation | 0.96094951 |
| 64 | MP0002723_abnormal_immune_serum | 0.94833239 |
| 65 | MP0001764_abnormal_homeostasis | 0.93559662 |
| 66 | MP0001661_extended_life_span | 0.93290760 |
| 67 | MP0000465_gastrointestinal_hemorrhage | 0.92508362 |
| 68 | MP0003011_delayed_dark_adaptation | 0.91897742 |
| 69 | MP0004883_abnormal_blood_vessel | 0.91198286 |
| 70 | MP0009764_decreased_sensitivity_to | 0.90310480 |
| 71 | MP0004130_abnormal_muscle_cell | 0.90175205 |
| 72 | * MP0001845_abnormal_inflammatory_respons | 0.89286396 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.89219440 |
| 74 | MP0001851_eye_inflammation | 0.87613504 |
| 75 | MP0009642_abnormal_blood_homeostasis | 0.85268829 |
| 76 | MP0005670_abnormal_white_adipose | 0.84424802 |
| 77 | MP0005000_abnormal_immune_tolerance | 0.84071897 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.83886043 |
| 79 | MP0001873_stomach_inflammation | 0.83408582 |
| 80 | MP0005647_abnormal_sex_gland | 0.82952477 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 0.81649305 |
| 82 | * MP0002419_abnormal_innate_immunity | 0.81559131 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.79682751 |
| 84 | MP0003091_abnormal_cell_migration | 0.78456265 |
| 85 | MP0000639_abnormal_adrenal_gland | 0.78040592 |
| 86 | MP0002998_abnormal_bone_remodeling | 0.77560974 |
| 87 | MP0002928_abnormal_bile_duct | 0.77516645 |
| 88 | MP0009697_abnormal_copulation | 0.76529626 |
| 89 | MP0003763_abnormal_thymus_physiology | 0.74982778 |
| 90 | * MP0005025_abnormal_response_to | 0.74869913 |
| 91 | * MP0002420_abnormal_adaptive_immunity | 0.74265088 |
| 92 | MP0002019_abnormal_tumor_incidence | 0.73348297 |
| 93 | * MP0001819_abnormal_immune_cell | 0.73084624 |
| 94 | MP0001853_heart_inflammation | 0.72348341 |
| 95 | MP0005636_abnormal_mineral_homeostasis | 0.71743233 |
| 96 | * MP0000689_abnormal_spleen_morphology | 0.71127330 |
| 97 | MP0005671_abnormal_response_to | 0.70041127 |
| 98 | MP0004043_abnormal_pH_regulation | 0.69528365 |
| 99 | MP0002009_preneoplasia | 0.69307377 |
| 100 | MP0004185_abnormal_adipocyte_glucose | 0.68908643 |
| 101 | MP0005334_abnormal_fat_pad | 0.67890047 |
| 102 | MP0002971_abnormal_brown_adipose | 0.66590022 |
| 103 | * MP0000716_abnormal_immune_system | 0.66342492 |
| 104 | MP0009115_abnormal_fat_cell | 0.66140269 |
| 105 | MP0001756_abnormal_urination | 0.65685697 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.65268528 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.64359930 |
| 108 | MP0003186_abnormal_redox_activity | 0.64282969 |
| 109 | MP0003329_amyloid_beta_deposits | 0.63737704 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.63678329 |
| 111 | MP0001545_abnormal_hematopoietic_system | 0.63381333 |
| 112 | MP0005397_hematopoietic_system_phenotyp | 0.63381333 |
| 113 | MP0010155_abnormal_intestine_physiology | 0.60892624 |
| 114 | MP0008874_decreased_physiological_sensi | 0.60847649 |
| 115 | MP0000249_abnormal_blood_vessel | 0.57848607 |
| 116 | MP0005023_abnormal_wound_healing | 0.56515226 |
| 117 | MP0005075_abnormal_melanosome_morpholog | 0.56246220 |
| 118 | MP0001348_abnormal_lacrimal_gland | 0.56227949 |
| 119 | MP0003724_increased_susceptibility_to | 0.56107890 |
| 120 | MP0009785_altered_susceptibility_to | 0.55569110 |
| 121 | * MP0002398_abnormal_bone_marrow | 0.55485839 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.54329793 |
| 123 | MP0008961_abnormal_basal_metabolism | 0.53020850 |
| 124 | MP0002722_abnormal_immune_system | 0.52722205 |
| 125 | * MP0002429_abnormal_blood_cell | 0.50517358 |
| 126 | MP0005666_abnormal_adipose_tissue | 0.50209150 |
| 127 | MP0004381_abnormal_hair_follicle | 0.49354030 |
| 128 | MP0009053_abnormal_anal_canal | 0.47829556 |
| 129 | MP0001533_abnormal_skeleton_physiology | 0.47504844 |
| 130 | MP0002933_joint_inflammation | 0.47409248 |
| 131 | MP0002405_respiratory_system_inflammati | 0.47285241 |
| 132 | MP0005166_decreased_susceptibility_to | 0.47088543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.21242733 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.02302386 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 5.99570386 |
| 4 | Xanthomatosis (HP:0000991) | 5.68725088 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.54890407 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.34650598 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 5.14027536 |
| 8 | Complement deficiency (HP:0004431) | 5.11208235 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 4.94337295 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 4.32339937 |
| 11 | Joint hemorrhage (HP:0005261) | 4.30778050 |
| 12 | Epidermoid cyst (HP:0200040) | 4.17603934 |
| 13 | Hypolipoproteinemia (HP:0010981) | 3.97740921 |
| 14 | Gastrointestinal stroma tumor (HP:0100723) | 3.82558298 |
| 15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.74011340 |
| 16 | Abnormality of complement system (HP:0005339) | 3.70868342 |
| 17 | Meningitis (HP:0001287) | 3.69540965 |
| 18 | Myocardial infarction (HP:0001658) | 3.65540227 |
| 19 | Hypoalphalipoproteinemia (HP:0003233) | 3.61853626 |
| 20 | Hyperammonemia (HP:0001987) | 3.54967335 |
| 21 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.53281193 |
| 22 | Ketosis (HP:0001946) | 3.52046743 |
| 23 | Fat malabsorption (HP:0002630) | 3.42659585 |
| 24 | Hypoglycemic coma (HP:0001325) | 3.33325331 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.33020966 |
| 26 | Hypercholesterolemia (HP:0003124) | 3.30023711 |
| 27 | Purpura (HP:0000979) | 3.24555604 |
| 28 | Eczematoid dermatitis (HP:0000976) | 3.23895616 |
| 29 | Abnormality of methionine metabolism (HP:0010901) | 3.22071966 |
| 30 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.21735111 |
| 31 | Mitral stenosis (HP:0001718) | 3.21032915 |
| 32 | Hyperglycinemia (HP:0002154) | 3.20284557 |
| 33 | Conjugated hyperbilirubinemia (HP:0002908) | 3.11134965 |
| 34 | Vasculitis (HP:0002633) | 3.10719700 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 3.08692925 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.04949089 |
| 37 | Glomerulonephritis (HP:0000099) | 3.03918888 |
| 38 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.01743326 |
| 39 | Epistaxis (HP:0000421) | 2.99473849 |
| 40 | Panhypogammaglobulinemia (HP:0003139) | 2.90449058 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.90237626 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.85090740 |
| 43 | Cellulitis (HP:0100658) | 2.81240707 |
| 44 | Lymphopenia (HP:0001888) | 2.78831637 |
| 45 | IgM deficiency (HP:0002850) | 2.77434047 |
| 46 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77372242 |
| 47 | Abnormality of glycine metabolism (HP:0010895) | 2.77372242 |
| 48 | Gastrointestinal infarctions (HP:0005244) | 2.76169767 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.74467318 |
| 50 | Prolonged bleeding time (HP:0003010) | 2.74282839 |
| 51 | Gingival bleeding (HP:0000225) | 2.71832414 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.67749080 |
| 53 | Hyperglycinuria (HP:0003108) | 2.67146619 |
| 54 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.67058283 |
| 55 | Esophageal varix (HP:0002040) | 2.66145745 |
| 56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.64643527 |
| 57 | Ketoacidosis (HP:0001993) | 2.63139288 |
| 58 | Abnormality of nucleobase metabolism (HP:0010932) | 2.58606065 |
| 59 | Spontaneous abortion (HP:0005268) | 2.54620319 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.54379956 |
| 61 | Recurrent abscess formation (HP:0002722) | 2.54290120 |
| 62 | Recurrent otitis media (HP:0000403) | 2.53808257 |
| 63 | Agammaglobulinemia (HP:0004432) | 2.53397356 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.53288833 |
| 65 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.53030682 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.53030682 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.53021472 |
| 68 | Skin nodule (HP:0200036) | 2.52587390 |
| 69 | Hyperbilirubinemia (HP:0002904) | 2.50354162 |
| 70 | Steatorrhea (HP:0002570) | 2.49269121 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.47624927 |
| 72 | Optic neuritis (HP:0100653) | 2.47624927 |
| 73 | Colitis (HP:0002583) | 2.46063909 |
| 74 | Hypoglycemic seizures (HP:0002173) | 2.45994156 |
| 75 | Hypochromic microcytic anemia (HP:0004840) | 2.45814811 |
| 76 | IgA deficiency (HP:0002720) | 2.45461254 |
| 77 | Abnormality of macrophages (HP:0004311) | 2.44691939 |
| 78 | Nephritis (HP:0000123) | 2.43026228 |
| 79 | Bronchitis (HP:0012387) | 2.42782333 |
| 80 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.41771003 |
| 81 | Encephalitis (HP:0002383) | 2.41065410 |
| 82 | Vascular calcification (HP:0004934) | 2.39635265 |
| 83 | Recurrent skin infections (HP:0001581) | 2.32123296 |
| 84 | Abnormal platelet function (HP:0011869) | 2.29689528 |
| 85 | Impaired platelet aggregation (HP:0003540) | 2.29689528 |
| 86 | Myositis (HP:0100614) | 2.28073033 |
| 87 | Orchitis (HP:0100796) | 2.27407817 |
| 88 | Emphysema (HP:0002097) | 2.25165504 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.23460777 |
| 90 | Obstructive lung disease (HP:0006536) | 2.23460777 |
| 91 | Osteomyelitis (HP:0002754) | 2.18772504 |
| 92 | T lymphocytopenia (HP:0005403) | 2.17515585 |
| 93 | Thrombophlebitis (HP:0004418) | 2.14199384 |
| 94 | Late onset (HP:0003584) | 2.13761217 |
| 95 | Pulmonary infiltrates (HP:0002113) | 2.13086025 |
| 96 | Hemorrhage of the eye (HP:0011885) | 2.12961397 |
| 97 | Pulmonary embolism (HP:0002204) | 2.12796182 |
| 98 | Spastic diplegia (HP:0001264) | 2.12381457 |
| 99 | Amyloidosis (HP:0011034) | 2.11236613 |
| 100 | Cardiovascular calcification (HP:0011915) | 2.11079529 |
| 101 | Recurrent pneumonia (HP:0006532) | 2.10583359 |
| 102 | Verrucae (HP:0200043) | 2.10557104 |
| 103 | Papilloma (HP:0012740) | 2.10557104 |
| 104 | Abnormality of T cell number (HP:0011839) | 2.10034940 |
| 105 | Viral hepatitis (HP:0006562) | 2.07844013 |
| 106 | Acanthocytosis (HP:0001927) | 2.06850611 |
| 107 | Abnormality of T cells (HP:0002843) | 2.06783793 |
| 108 | Abnormal tarsal ossification (HP:0008369) | 2.05619314 |
| 109 | Gout (HP:0001997) | 2.04700036 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.03580734 |
| 111 | Acute hepatic failure (HP:0006554) | 2.03447624 |
| 112 | Menorrhagia (HP:0000132) | 2.02856813 |
| 113 | Arterial thrombosis (HP:0004420) | 2.02836270 |
| 114 | Increased IgE level (HP:0003212) | 2.01747364 |
| 115 | Sensorimotor neuropathy (HP:0007141) | 2.01209853 |
| 116 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00091275 |
| 117 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00091275 |
| 118 | Chronic otitis media (HP:0000389) | 1.99334921 |
| 119 | Abnormality of the fingertips (HP:0001211) | 1.98712795 |
| 120 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98662655 |
| 121 | Gangrene (HP:0100758) | 1.98378043 |
| 122 | Abnormality of T cell physiology (HP:0011840) | 1.96744174 |
| 123 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96076233 |
| 124 | Joint swelling (HP:0001386) | 1.95590481 |
| 125 | Skin rash (HP:0000988) | 1.94900568 |
| 126 | Recurrent sinusitis (HP:0011108) | 1.94559822 |
| 127 | Hypochromic anemia (HP:0001931) | 1.93217339 |
| 128 | Autoimmune hemolytic anemia (HP:0001890) | 1.93054889 |
| 129 | Increased CSF protein (HP:0002922) | 1.93015452 |
| 130 | Irritability (HP:0000737) | 1.92974884 |
| 131 | Delayed CNS myelination (HP:0002188) | 1.92768463 |
| 132 | Hyperactive renin-angiotensin system (HP:0000841) | 1.92336892 |
| 133 | Inflammation of the large intestine (HP:0002037) | 1.92130738 |
| 134 | Spontaneous hematomas (HP:0007420) | 1.92011052 |
| 135 | Small epiphyses (HP:0010585) | 1.89100503 |
| 136 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88870952 |
| 137 | Abnormality of serum amino acid levels (HP:0003112) | 1.88808556 |
| 138 | Restrictive lung disease (HP:0002091) | 1.87583852 |
| 139 | Lymphoma (HP:0002665) | 1.86074306 |
| 140 | Gastrointestinal inflammation (HP:0004386) | 1.85571989 |
| 141 | Chronic diarrhea (HP:0002028) | 1.85353190 |
| 142 | Back pain (HP:0003418) | 1.85142899 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.83662790 |
| 144 | Metabolic acidosis (HP:0001942) | 1.82568778 |
| 145 | Malnutrition (HP:0004395) | 1.81934073 |
| 146 | Peripheral demyelination (HP:0011096) | 1.80140945 |
| 147 | Pancreatitis (HP:0001733) | 1.79321906 |
| 148 | Abnormal gallbladder morphology (HP:0012437) | 1.78939616 |
| 149 | Polycythemia (HP:0001901) | 1.78212033 |
| 150 | Recurrent bronchitis (HP:0002837) | 1.77192163 |
| 151 | Glomerulosclerosis (HP:0000096) | 1.76129741 |
| 152 | Axonal loss (HP:0003447) | 1.74999795 |
| 153 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.73151198 |
| 154 | Focal segmental glomerulosclerosis (HP:0000097) | 1.71314123 |
| 155 | Increased mean platelet volume (HP:0011877) | 1.70411527 |
| 156 | Recurrent viral infections (HP:0004429) | 1.70060576 |
| 157 | Hepatitis (HP:0012115) | 1.67969630 |
| 158 | Elevated hepatic transaminases (HP:0002910) | 1.67347053 |
| 159 | Cholelithiasis (HP:0001081) | 1.67158603 |
| 160 | Neonatal onset (HP:0003623) | 1.66442969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.21407721 |
| 2 | RIPK4 | 3.93332710 |
| 3 | PRPF4B | 3.81091558 |
| 4 | MAP4K1 | 3.63318328 |
| 5 | SIK1 | 3.62450531 |
| 6 | FGFR4 | 3.56143668 |
| 7 | TRIB3 | 3.30888538 |
| 8 | PKN2 | 2.89331900 |
| 9 | MAP3K10 | 2.77223765 |
| 10 | BCKDK | 2.58048885 |
| 11 | SMG1 | 2.19958326 |
| 12 | TYK2 | 2.15393627 |
| 13 | GRK6 | 2.14786657 |
| 14 | TAOK3 | 2.00771189 |
| 15 | PTK6 | 1.87404794 |
| 16 | CAMK1D | 1.75581827 |
| 17 | JAK1 | 1.73174154 |
| 18 | TGFBR2 | 1.67420126 |
| 19 | INSRR | 1.66081331 |
| 20 | EEF2K | 1.63996891 |
| 21 | FGFR2 | 1.62433813 |
| 22 | EPHB1 | 1.61626369 |
| 23 | STK10 | 1.59491429 |
| 24 | CSF1R | 1.52082685 |
| 25 | CAMK1G | 1.50817519 |
| 26 | IRAK4 | 1.50670475 |
| 27 | ITK | 1.49602573 |
| 28 | FES | 1.48307499 |
| 29 | MAP3K14 | 1.43969780 |
| 30 | LRRK2 | 1.41908483 |
| 31 | FGFR3 | 1.41533346 |
| 32 | TBK1 | 1.41314089 |
| 33 | MAP3K13 | 1.32483975 |
| 34 | JAK3 | 1.30145455 |
| 35 | ZAP70 | 1.29484215 |
| 36 | FRK | 1.23398213 |
| 37 | FLT3 | 1.23203030 |
| 38 | MAP3K7 | 1.21212152 |
| 39 | NEK9 | 1.17331727 |
| 40 | CSK | 1.16840392 |
| 41 | RIPK1 | 1.13913627 |
| 42 | TEC | 1.13392599 |
| 43 | EPHA3 | 1.12853469 |
| 44 | BLK | 1.11113602 |
| 45 | JAK2 | 1.10777364 |
| 46 | BTK | 1.07834049 |
| 47 | KDR | 1.02641341 |
| 48 | PIK3CG | 1.01557336 |
| 49 | LATS1 | 1.01488510 |
| 50 | IKBKE | 1.01412240 |
| 51 | MST1R | 1.00795763 |
| 52 | FGR | 1.00223219 |
| 53 | KSR2 | 1.00143610 |
| 54 | MAPK11 | 0.98394900 |
| 55 | SYK | 0.97239361 |
| 56 | SIK3 | 0.96339761 |
| 57 | CDC42BPA | 0.93319034 |
| 58 | PASK | 0.92158643 |
| 59 | PRKCQ | 0.89056304 |
| 60 | EIF2AK3 | 0.88128861 |
| 61 | MARK3 | 0.85891164 |
| 62 | PRKCH | 0.85611401 |
| 63 | MAP3K1 | 0.82461347 |
| 64 | MARK2 | 0.81879734 |
| 65 | PRKAA2 | 0.78163111 |
| 66 | TNK2 | 0.78144218 |
| 67 | DYRK1B | 0.77052668 |
| 68 | CHUK | 0.75416859 |
| 69 | YES1 | 0.75070115 |
| 70 | RET | 0.74796064 |
| 71 | SGK2 | 0.73795687 |
| 72 | HCK | 0.71980597 |
| 73 | CDK6 | 0.71512649 |
| 74 | MAPK15 | 0.69828717 |
| 75 | MET | 0.66813577 |
| 76 | LCK | 0.66244837 |
| 77 | SGK3 | 0.65981366 |
| 78 | NLK | 0.65453479 |
| 79 | BMPR2 | 0.62299736 |
| 80 | ERBB4 | 0.61845346 |
| 81 | SIK2 | 0.60815489 |
| 82 | PDGFRA | 0.60326928 |
| 83 | STK24 | 0.60305204 |
| 84 | MAPK12 | 0.60239553 |
| 85 | MAP3K3 | 0.60179025 |
| 86 | CDK12 | 0.60051060 |
| 87 | IKBKB | 0.57516633 |
| 88 | CSNK1A1L | 0.56995342 |
| 89 | LYN | 0.56165570 |
| 90 | GSK3A | 0.55653081 |
| 91 | PTK2 | 0.55459387 |
| 92 | MATK | 0.55248893 |
| 93 | CSNK1G1 | 0.54996647 |
| 94 | KIT | 0.54763201 |
| 95 | PDGFRB | 0.54279217 |
| 96 | MTOR | 0.53981531 |
| 97 | PRKD1 | 0.53972496 |
| 98 | BRD4 | 0.53818332 |
| 99 | MAPK7 | 0.53373932 |
| 100 | MAP3K2 | 0.53372100 |
| 101 | HIPK2 | 0.49923734 |
| 102 | EGFR | 0.49251247 |
| 103 | MST4 | 0.48184412 |
| 104 | MAPK4 | 0.47592785 |
| 105 | PDK1 | 0.47295572 |
| 106 | IGF1R | 0.46973813 |
| 107 | ALK | 0.46204541 |
| 108 | BMX | 0.46118022 |
| 109 | MAP3K8 | 0.45391320 |
| 110 | PRKCZ | 0.44723150 |
| 111 | ICK | 0.44110692 |
| 112 | SGK223 | 0.44075503 |
| 113 | SGK494 | 0.44075503 |
| 114 | MELK | 0.43558116 |
| 115 | TAOK2 | 0.42712626 |
| 116 | FYN | 0.41291078 |
| 117 | INSR | 0.40809693 |
| 118 | ABL1 | 0.40698226 |
| 119 | TXK | 0.40411829 |
| 120 | MAP2K3 | 0.39142466 |
| 121 | TYRO3 | 0.38860556 |
| 122 | CAMKK1 | 0.37864612 |
| 123 | IRAK1 | 0.37548135 |
| 124 | DAPK2 | 0.37499067 |
| 125 | CDK4 | 0.37164932 |
| 126 | PDPK1 | 0.37005211 |
| 127 | IRAK3 | 0.36886860 |
| 128 | PIM1 | 0.36867952 |
| 129 | CDK9 | 0.36648416 |
| 130 | MAP2K2 | 0.35143392 |
| 131 | PRKAA1 | 0.33480043 |
| 132 | MAPK3 | 0.28412208 |
| 133 | MAP3K5 | 0.26462772 |
| 134 | MAPKAPK2 | 0.26460676 |
| 135 | MAP3K11 | 0.26413655 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13431046 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.81662067 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.28583142 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25020971 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.00625043 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.93175357 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.76024149 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.65964270 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54492425 |
| 10 | Allograft rejection_Homo sapiens_hsa05330 | 2.50549994 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.40286270 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34703032 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28466239 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26088397 |
| 15 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22040768 |
| 16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.16122247 |
| 17 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.15432260 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.02281618 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93025001 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.91524492 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.87392257 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.86004014 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.78264398 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76417814 |
| 25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.73524233 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.71650435 |
| 27 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69753074 |
| 28 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64858705 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.62935416 |
| 30 | Asthma_Homo sapiens_hsa05310 | 1.61303315 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.60185537 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58681392 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.52054999 |
| 34 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.46169256 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.43828842 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.42915995 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.40466248 |
| 38 | ABC transporters_Homo sapiens_hsa02010 | 1.37601767 |
| 39 | Retinol metabolism_Homo sapiens_hsa00830 | 1.36979953 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34698157 |
| 41 | Viral myocarditis_Homo sapiens_hsa05416 | 1.33991537 |
| 42 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.30232419 |
| 43 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.29315391 |
| 44 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28490366 |
| 45 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.27297451 |
| 46 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.26654613 |
| 47 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23439406 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.18593235 |
| 49 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.15438778 |
| 50 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12970119 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.12131845 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.10719031 |
| 53 | Lysine degradation_Homo sapiens_hsa00310 | 1.07418287 |
| 54 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07309278 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.06538882 |
| 56 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.05467626 |
| 57 | Other glycan degradation_Homo sapiens_hsa00511 | 1.03352957 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.97147841 |
| 59 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.93112414 |
| 60 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91362693 |
| 61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.88414616 |
| 62 | Tuberculosis_Homo sapiens_hsa05152 | 0.85487866 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83790755 |
| 64 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.82340887 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82019897 |
| 66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81308690 |
| 67 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.76126041 |
| 68 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75420115 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74848294 |
| 70 | Hepatitis B_Homo sapiens_hsa05161 | 0.71279098 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70530480 |
| 72 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.66178971 |
| 73 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.65097105 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.63749844 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.62215145 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.61470586 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60742415 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.60697153 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60392871 |
| 80 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58953607 |
| 81 | Platelet activation_Homo sapiens_hsa04611 | 0.58822510 |
| 82 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54016956 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52225155 |
| 84 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50701705 |
| 85 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49932818 |
| 86 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.48746031 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46558109 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46340494 |
| 89 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45144731 |
| 90 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44993272 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.44179522 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.43878941 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.43831713 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.42346757 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41314135 |
| 96 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38921546 |
| 97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.38510081 |
| 98 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37249995 |
| 99 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37157380 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.37118589 |
| 101 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.36645596 |
| 102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.36002136 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.35348402 |
| 104 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35199373 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.34867969 |
| 106 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.32956813 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.32707975 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32529550 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.29710211 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25424853 |
| 111 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.23604737 |
| 112 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.23140338 |
| 113 | Lysosome_Homo sapiens_hsa04142 | 0.20360332 |
| 114 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20102707 |
| 115 | Galactose metabolism_Homo sapiens_hsa00052 | 0.20069974 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.17314572 |
| 117 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.17275037 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.17145907 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.16625887 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.16399344 |
| 121 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.14165676 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.13738686 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09706219 |
| 124 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.09300025 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.07977642 |
| 126 | Measles_Homo sapiens_hsa05162 | 0.06958242 |
| 127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06836734 |
| 128 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.05496340 |
| 129 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.05189547 |
| 130 | Pertussis_Homo sapiens_hsa05133 | 0.04913110 |
| 131 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.04868913 |
| 132 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.04494618 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.04361165 |
| 134 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.02862320 |
| 135 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.01356314 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.00051910 |

